Evidence map›Paper›PMID 20459693›Full record

ArticleRespiratory research2010

Effects of perfluorocarbons on surfactant exocytosis and membrane properties in isolated alveolar type II cells.

Andreas Wemhöner, Irmgard Hackspiel, Nina Hobi, Andrea Ravasio, Thomas Haller, Mario Rüdiger

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Andreas WemhönerUniversity Hospital Dresden, Department for Pediatric Intensive Care and Neonatology, Technical University Dresden, Germany.
Irmgard Hackspiel
Nina Hobi
Andrea Ravasio
Thomas Haller
Mario Rüdiger
Innsbruck Medical University · ATTU Dresden · DE

Funding

Austrian Science Fund FWF P 17501Austrian Science Fund FWF P 20472
6 · The paper itself

Abstract

backgroundPerfluorocarbons (PFC) are used to improve gas exchange in diseased lungs. PFC have been shown to affect various cell types. Thus, effects on alveolar type II (ATII) cells and surfactant metabolism can be expected, data, however, are controversial.

objectiveThe study was performed to test two hypotheses: (I) the effects of PFC on surfactant exocytosis depend on their respective vapor pressures; (II) different pathways of surfactant exocytosis are affected differently by PFC.

methodsIsolated ATII cells were exposed to two PFC with different vapor pressures and spontaneous surfactant exocytosis was measured. Furthermore, surfactant exocytosis was stimulated by either ATP, PMA or ionomycin. The effects of PFC on cell morphology, cellular viability, endocytosis, membrane permeability and fluidity were determined.

resultsThe spontaneous exocytosis was reduced by PFC, however, the ATP and PMA stimulated exocytosis was slightly increased by PFC with high vapor pressure. In contrast, Ionomycin-induced exocytosis was decreased by PFC with low vapor pressure. Cellular uptake of FM 1-43 - a marker of membrane integrity - was increased. However, membrane fluidity, endocytosis and viability were not affected by PFC incubation.

conclusionsWe conclude that PFC effects can be explained by modest, unspecific interactions with the plasma membrane rather than by specific interactions with intracellular targets.

Indexed as

Adenosine TriphosphateAlveolar Epithelial CellsAnimalsCell Line, TumorCell MembraneCell Membrane PermeabilityCell ShapeCell SurvivalExocytosisFluorocarbonsHumansIonomycinMaleMembrane FluidityPulmonary Surfactant-Associated ProteinsRatsAdenosine TriphosphateFluorocarbonsIonomycinperfluorodecalinperfluoromethylcyclohexanePulmonary Surfactant-Associated ProteinsTetradecanoylphorbol Acetate

Identifiers

PMID20459693
PMCPMC2876085
OpenAlexW2103078773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.